Sign in
Active, not recruitingNo phase

SEDVasc (RaDiCo Cohort) (RaDiCo-SEDVasc)

Key facts

Who runs it
Institut National de la Santé Et de la Recherche Médicale, France
Where
France17 sites in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
340 people enrolled
Started
5 Dec 2016
Expected to end
Jan 2028
Type of study
Observational
Record updated
12 February 2026

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Patients eligible for inclusion in this study have to fulfil all of the following criteria:
  • Patients (adults and children) with genetically-proven vEDS (presence of a pathogenic mutation at the COL3A1 gene)
  • Patients (or his/her legal guardian) who does not oppose to his/her personal data collection; There are no exclusion criteria for this study

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this observational study is to describe the natural course of vascular Ehlers-Danlos syndrome, in particular the order of appearance of different types of complications (arterial, digestive, pulmonary and uterine).

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
National Cohort on the Vascular Ehlers-Danlos Syndrome (SEDv)
Record updated
12 February 2026